COVID-19 Plan: Checklists for Chronic Lymphocytic Leukemia (CLL) Preparing for Pre and Post COVID-19 Exposure
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
What You Need to Know about BTK Inhibitors as Treatment
for Your/Your Loved One’s CLL
Recorded August 10, 2020
In this archived virtual event, you will hear from a hematologist specializing in CLL, a nurse practitioner, and a CLL patient as they discuss what you need to know about BTK inhibitors (e.g. ibrutinib [Imbruvica], acalabrutinib [Calquence]). The esteemed panel addresses audience questions, discuss complications, and reveal strategies to optimize management of your or your loved one’s CLL. During this virtual event, you will be exposed to strategies that can help in shared decision-making (does not put the responsibility for outcomes on CLLS) regarding treatment choices, side-effect monitoring, and locating and using support resources.
Please note, CancerCoach Live does require you to sign up to watch the archived webinar.
Related posts
